Emerging neurological biomarkers enabling personalized care is fastest growing segment fueling the growth of Neurological Biomarkers Market

-


The global Neurological Biomarkers Market is estimated to be valued at US$ 11813.64 Mn in 2023 and is expected to exhibit a CAGR of 14% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
Neurological biomarkers are indicators of normal or pathogenic biological processes measured from body fluids or tissues that assist in the evaluation of neurological status and progression. They aid in various processes associated with neurological disorders including diagnosis, monitoring disease progression, and assessing response to treatment.

Market key trends:
One of the key trends fueling the growth of this market is the ability of neurological biomarkers to enable precision and personalized medicine. Biomarkers are being used for preclinical diagnosis, risk assessment, prognosis, and tailored treatment approaches for neurological conditions. They help identify patient subtypes and endophenotypes based on molecular signatures which can guide clinical decision making. This allows for stratified or personalized medicine approaches specific to patient characteristics, advancing from a “one-size-fits-all” model of care. Furthermore, biomarkers support the evaluation of new drugs during clinical trials by providing quantitative measures of disease processes or treatment responses.

Segment Analysis
The global neurological biomarkers market size is segmented into proein biomarkers, genetic biomarkers and imaging biomarkers. Among these, imaging biomarkers dominates the market and accounts for around 35% of the total market share. Imaging biomarkers provides non-invasive diagnosis of neurological disorders by providing anatomical and functional information about brain structure and activities. This segment experiences high demand owing to its ability to identify neurological changes at an early stage.

Key Takeaways
The global neurological biomarkers market is expected to witness high growth, exhibiting CAGR of 14.% over the forecast period, due to increasing prevalence of neurological disorders worldwide.

Regional analysis
Asia Pacific region is expected to grow at the fastest CAGR over the forecast period due to rising healthcare expenditure and increasing prevalence of neurological diseases in the region. North America currently dominates the global market owing to presence of major players and advanced healthcare infrastructure in the region.

Key players
Key players operating in the neurological biomarkers market are Abbott Laboratories, QIAGEN N.V., Myriad RBM, Thermo Fisher Scientific Inc., Athena Diagnostics, Bio-Rad Laboratories, Inc., AbaStar MDx, Inc., Acumen Pharmaceuticals, Banyan Biomarkers, Inc., Alseres Pharmaceuticals, Inc., Proteome Sciences, Immunarray Pvt. Ltd., Quanterix Corporation, Diagenic ASA, and Psynova Neurotech. Major players are focusing on developing advanced biomarkers and investing in R&D activities to strengthen their market position.

Comments

Post a Comment

Popular posts from this blog

The global Ion Exchange Membrane Market Growth Accelerated by Increasing Industrialization and Urbanization

-
Image
Ion exchange membranes are selectively permeable membranes that transport ions from one solution to another by ion exchange. They are used in various applications such as water purification, wastewater treatment, chlor-alkali industry, and fuel cells. The increasing industrialization and urbanization is creating a huge demand for water and power. Ion exchange membranes help provide clean water and green energy production through desalination and fuel cells. The global Ion Exchange Membrane Market is estimated to be valued at US$ 908.33 Mn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing industrialization and urbanization is one of the key trends driving the growth of the ion exchange membrane market. As industries expand production and urban populations increase globally, the demand for drinking water and power rises substantially. Ion exc
Read more

Healthcare IT (HCIT) is fastest growing segment fueling the growth of Drug for Abuse Testing Devices Market

-
Image
The global Drug For Abuse Testing Devices Market is estimated to be valued at US$ 1.65 Bn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Drug for abuse testing devices help identify the presence of drugs or metabolites in the body by analyzing samples such as urine, blood, hair, oral fluid etc. These products play an important role in drug screening programs by ensuring job security, public safety and health. Market key trends: The adoption of healthcare IT solutions is one of the key trends witnessed in the drug for abuse testing devices market. Integration of IT with diagnostic products helps generate faster and accurate test results while streamlining workflow. IT solutions also enable efficient data management and sharing of reports between labs and law enforcement agencies. This significantly improves monitoring and prevention of drug abuse in the s
Read more

Electric Powertrain Market Growth Accelerated by Adoption of Stringent Emission Regulations

-
Image
The electric powertrain incorporates electric motor, power electronics, and transmission and helps convert energy from external power supply into mechanical energy in electric vehicles. Growing demand for zero-emission and fuel-efficient vehicles coupled with stringent emission regulations imposed by regulatory bodies globally are anticipated to drive the demand for electric powertrains. Additionally, development of high-performance lithium-ion batteries with high energy density at affordable costs has facilitated automakers to adopt electric powertrains in their vehicles. The global Electric Powertrain Market is estimated to be valued at US$ 81.7 Bn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Adoption of stringent emission regulations imposed by governmental organizations across the globe to curb carbon emissions is a key trend fueling the growth of
Read more